位置：成果数据库 > 期刊 > 期刊详情页
Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and met
  • ISSN号：1471-2407
  • 期刊名称：BMC Cancer
  • 时间：2013.10.15
  • 页码：-
  • 相关项目：肿瘤相关巨噬细胞来源的肾上腺髓质素在新生血管生成、肿瘤生长和转移中的作用与机制研究
作者： Li, Liang|Li, Yi|Luo, Yongzhang|Zhen, Yong-su|
同期刊论文项目
肿瘤相关巨噬细胞来源的肾上腺髓质素在新生血管生成、肿瘤生长和转移中的作用与机制研究
期刊论文 16
同项目期刊论文
The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1.
Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-5
Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibod
MicroRNA-542-3p inhibits tumour angiogenesis by targeting Angiopoietin-2
The regulatory mechanism of a client kinase controlling its own release from Hsp90 chaperone machine
Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cyt
Endostatin Prevents Dietary-Induced Obesity by Inhibiting Adipogenesis and Angiogenesis.
High expression of small GTPase Rab3D promotes cancer progression and metastasis.
Endostatin has ATPase activity, which mediates its antiangiogenic and antitumor activities.
PLCgamma1-PKCgamma signaling-mediated Hsp90alpha plasma membrane translocation facilitates tumor met
The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct
Heat Shock Cognate 70 Regulates the Translocation and Angiogenic Function of Nucleolin